Company Filing History:
7 out of 243 
1 out of 832,718 Years Active: 1991-2021
Title: The Innovative Contributions of Dorothee Herlyn
Introduction
Dorothee Herlyn is a prominent inventor based in Wynnewood, PA (US). She has made significant contributions to the field of melanoma treatment, holding a total of 8 patents. Her work focuses on developing methods and compositions that enhance the treatment of this aggressive skin cancer.
Latest Patents
Herlyn's latest patents include innovative methods and compositions for treating melanoma. One notable patent describes compositions that include BRAF-based peptides, either alone or in combination with T helper peptides. These compositions also encompass nucleic acid sequences encoding the BRAF-based peptides. Additionally, dendritic cells pretreated with these peptides are provided, which can be co-administered with antibodies to checkpoint inhibitors or molecules that mimic their action. Another patent highlights novel BRAF mutant peptides that induce MHC Class I-dependent cytotoxic T cell responses in mammals, proving useful in prophylactic, diagnostic, and therapeutic treatments for melanoma.
Career Highlights
Throughout her career, Dorothee Herlyn has worked at esteemed institutions such as The Wistar Institute of Anatomy & Biology and The Wistar Institute. Her research has significantly advanced the understanding and treatment of melanoma, making her a key figure in the field.
Collaborations
Herlyn has collaborated with notable colleagues, including Hilary Koprowski and Meenhard Herlyn. These partnerships have further enriched her research and contributions to melanoma treatment.
Conclusion
Dorothee Herlyn's innovative work in developing treatments for melanoma showcases her dedication to advancing medical science. Her contributions continue to impact the field significantly, providing hope for improved therapeutic options for patients.